分泌 BiTE 的 CAR-γδT 作为实体瘤治疗的双靶向策略
BiTE-Secreting CAR-γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors.
HLA-G 被认为是一种免疫检查点蛋白和肿瘤相关抗原。
62.9分
★★★☆☆
FRONTIER PAPERS
BiTE-Secreting CAR-γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors.
HLA-G 被认为是一种免疫检查点蛋白和肿瘤相关抗原。
Bispecific CAR T and CAR NK cells in dual-threat immunotherapy: opportunities and challenges.
抗原逃逸和瘤内异质性仍是基于嵌合抗原受体(CAR)的肿瘤免疫治疗实现持久缓解的主要障碍。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。